Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
Clinical trial NCT06763029 · RECRUITING
Trial details
- NCT number
- NCT06763029
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-26
- Primary completion
- 2026-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.